McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 403.43B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.58% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 403.43B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 10.68%.
Undervalued
The company’s latest PE is 19.33, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 112.82M shares, decreasing 2.46% quarter-over-quarter.
Held by Steve Mandel
Star Investor Steve Mandel holds 448.68K shares of this stock.